A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

The main purpose of this 3-part study is to evaluate the safety and efficacy of the study drug known as LY2880070 in participants with advanced or metastatic solid tumors.本项分为三部分的研究的主要目的是评估名为LY2880070的研究药物在晚期或转移性实体瘤受试者中的安全性与有效性。